BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19906050)

  • 1. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
    Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
    Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
    J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
    Srivastava M; Perez-Atayde A; Jonas MM
    Gastroenterology; 1998 Sep; 115(3):743-6. PubMed ID: 9721172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome as an unusual adverse effect of azithromycin.
    Brkljacić N; Gracin S; Prkacin I; Sabljar-Matovinović M; Mrzljak A; Nemet Z
    Acta Dermatovenerol Croat; 2006; 14(1):40-5. PubMed ID: 16603101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
    Okan G; Yaylaci S; Peker O; Kaymakoglu S; Saruc M
    World J Gastroenterol; 2008 Aug; 14(29):4697-700. PubMed ID: 18698687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case.
    Cavanzo FJ; Garcia CF; Botero RC
    Gastroenterology; 1990 Sep; 99(3):854-6. PubMed ID: 2116345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.
    Garcia M; Mhanna MJ; Chung-Park MJ; Davis PH; Srivastava MD
    Dig Dis Sci; 2002 Jan; 47(1):177-82. PubMed ID: 11837721
    [No Abstract]   [Full Text] [Related]  

  • 8. Moxifloxacin associated vanishing bile duct syndrome.
    Robinson W; Habr F; Manlolo J; Bhattacharya B
    J Clin Gastroenterol; 2010 Jan; 44(1):72-3. PubMed ID: 19581811
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic acid-associated vanishing bile duct syndrome.
    Gökçe S; Durmaz O; Celtik C; Aydogan A; Güllüoglu M; Sökücü S
    J Child Neurol; 2010 Jul; 25(7):909-11. PubMed ID: 20388938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol].
    Choi SH; Yang SH; Song YB; Kim HJ; Seo YT; Choi DS; Moon KH; Byun JH; Yu ES
    Korean J Hepatol; 2005 Mar; 11(1):80-5. PubMed ID: 15788888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced vanishing bile duct syndrome: response to ursodiol.
    O'Brien CB; Shields DS; Saul SH; Reddy KR
    Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
    [No Abstract]   [Full Text] [Related]  

  • 12. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis.
    Lin WC; Hsieh TS; Chu CY
    Front Med (Lausanne); 2022; 9():975754. PubMed ID: 36353223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
    Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome from ophthalmic sulfonamide.
    Gottschalk HR; Stone OJ
    Arch Dermatol; 1976 Apr; 112(4):513-4. PubMed ID: 1267457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
    Vuppalanchi R; Chalasani N; Saxena R
    Am J Surg Pathol; 2006 Dec; 30(12):1619-23. PubMed ID: 17122520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing bile duct syndrome temporally associated with ibuprofen use.
    Alam I; Ferrell LD; Bass NM
    Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute vanishing bile duct syndrome after the use of ibuprofen.
    Basturk A; Artan R; Yılmaz A; Gelen MT; Duman O
    Arab J Gastroenterol; 2016 Sep; 17(3):137-139. PubMed ID: 27658326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
    Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
    Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.